Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Peramivir

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 7,996Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    U.S. Government Awards BioCryst $69 Million RAPIVAB Contract
    U.S. Government Awards BioCryst $69 Million RAPIVAB Contract

    30 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/en/news-release/2024/09/30/2955050/29446/en/U-S-Government-Awards-BioCryst-69-Million-RAPIVAB-peramivir-injection-Contract-for-Strategic-National-Stockpile.html

    GLOBENEWSWIRE
    30 Sep 2024
    Share Share
    NV-387 Broad-Spectrum Antiviral Could Combat Bird Flu H5N1, Says NanoViricides
    NV-387 Broad-Spectrum Antiviral Could Combat Bird Flu H5N1, Says NanoViricides

    24 Jun 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=880873&lang=en

    ACCESSWIRE
    24 Jun 2024
    Share Share
    U.S. Government Exercises Option to Purchase Additional RAPIVAB from BioCryst
    U.S. Government Exercises Option to Purchase Additional RAPIVAB from BioCryst

    25 Aug 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/08/25/2504461/29446/en/U-S-Government-Exercises-Option-to-Purchase-Additional-RAPIVAB-peramivir-injection-from-BioCryst-for-Pandemic-Influenza-Preparedness.html

    GLOBENEWSWIRE
    25 Aug 2022
    Share Share
    U.S. Government Exercises Option to Purchase Additional RAPIVAB from BioCryst
    U.S. Government Exercises Option to Purchase Additional RAPIVAB from BioCryst

    01 Sep 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/09/01/2289871/29446/en/U-S-Government-Exercises-Option-to-Purchase-Additional-RAPIVAB-peramivir-injection-from-BioCryst-for-Delivery-to-Strategic-National-Stockpile.html

    GLOBENEWSWIRE
    01 Sep 2021
    Share Share
    BioCryst Announces FDA Approval of Supplemental NDAfor RAPIVAB®
    BioCryst Announces FDA Approval of Supplemental NDAfor RAPIVAB®

    03 Feb 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/biocryst-announces-fda-approval-of-supplemental-new-drug-application-for-rapivab-expanding-patient-population-to-include-children-six-months-and-older-/

    BIOSPACE
    03 Feb 2021
    Share Share
    BioCryst wins approval HAE pill charges half-a-M dollars, will anyone take it?
    BioCryst wins approval HAE pill charges half-a-M dollars, will anyone take it?

    07 Dec 2020

    // Jason Mast ENDPTS

    https://endpts.com/biocryst-wins-approval-for-hae-pill-and-charges-half-a-million-dollars-but-will-anyone-take-it/

    Jason Mast ENDPTS
    07 Dec 2020
    Share Share